Security key
925050106
Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (VRNA)
CUSIP: 925050106
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Ordinary Shares, nominal value 0.05 GBP per share
- Shares outstanding
- 84,213,667
- Total 13F shares
- 62,584,885
- Share change
- +2,404,481
- Total reported value
- $1,332,969,384
- Put/Call ratio
- 69%
- Price per share
- $21.14
- Number of holders
- 104
- Value change
- +$50,184,333
- Number of buys
- 46
- Number of sells
- 41
Report period
Q2 2023
Institutions
104
Top holders
10
Broader feeds
Reporting periods
Holder history for CUSIP 925050106
Recent filing periods:
Top shareholders of VRNA - Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (VRNA) as of Q2 2023
As of 30 Jun 2023,
Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (VRNA) was held by
104 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
62,584,885 shares.
The largest 10 holders included
FMR LLC, RA CAPITAL MANAGEMENT, L.P., NEA Management Company, LLC, PERCEPTIVE ADVISORS LLC, WELLINGTON MANAGEMENT GROUP LLP, Vivo Capital, LLC, ORBIMED ADVISORS LLC, Deep Track Capital, LP, Frazier Life Sciences Management, L.P., and Octagon Capital Advisors LP.
This page lists
104
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
93
Q2 2023 holders
104
Holder diff
11
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.